期刊文献+

胰腺癌的放射治疗进展 被引量:9

Development of radiation therapy for pancreatic carcinoma
原文传递
导出
摘要 胰腺癌高度恶性,手术可切除率低。放射治疗通过射线作用于肿瘤细胞DNA,引起细胞死亡以达到治疗目的,将其与化学治疗相联合的辅助治疗,对胰腺癌的综合治疗具有重要意义。该文回顾了近年来放射治疗在胰腺癌术前新辅助治疗、术后辅助治疗以及局部进展期治疗等方面取得的进展。放、化疗联合治疗对于不可切除胰腺癌病例的治疗意义尚需要更多更为可靠的循证医学证据来明确。 Adenocarcinoma of exocrine pancreas is a highly malignant tumor with extremely low resectability. Radiotherapy, by inducing necrosis and apoptosis of tumor cells through irradiation effects on cdlular DNA, in combination with chemotherapy, has made great contribution to muhimodal treatment of this malignancy. The development of radiation therapy for pancreatic carcinoma in recent years was reviewed in neoadjuvant and adjuvant settings, and for locally advanced disease. Further evidence is required to show the impact of radiochemotherapy in the treatment of unresectable disease.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2011年第11期944-947,共4页 Chinese Journal of Hepatobiliary Surgery
关键词 胰腺癌 放射治疗 放化疗联合治疗 辅助治疗 Pancreatic carcinoma Irradiation Radiochemotherapy Adjuvant therapy
  • 相关文献

参考文献27

  • 1Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. CA Cancer J Clin, 2010, 60:277-300.
  • 2赵玉沛.胰腺癌诊断与治疗的现状与未来[J].中华肝胆外科杂志,2009,15(5):321-323. 被引量:44
  • 3Pilepich MV, Miller HH. Preoperative irradiation in carcino- ma of the pancreas[J]. Cancer, 1980,46:1945-1949.
  • 4Lawrence TS, Chang EY, Hahn TM, et al. Radiosensitization of pancreatic cancer cells by 2' 2 '-difluoro-2 '-deoxycytidine [J]. Int ] Radiat Oneol Biol Phys, 1996,34:867-872.
  • 5Evans DB, Varadachary GR, Crane CH et al. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head[J]. J Clin Oncol, 2008, 26:3496 3502,.
  • 6Varadachary GR, Wolff RA, Crane CH, et al. Preoperative gemcitabine and cisplatin followed by gemcitabine-based che- moradiation for resectable adenocarcinoma of the pancreatic head[J]. J Clin Oncol, 2008,26:3487-3495.
  • 7McGinn CJ, Zalupski MM. Radiation therapy with once-week- ly gemcitabine in pancreatic cancer: current status of clinical trials[J]. Int J Radiat OncolBiol Phys, 2003, 56 (4 Suppl) 10-15.
  • 8McGinn CJ, Zalupski MM, Shureiqi 1, et al. Phase I trial of radiation dose escalation with concurrent weekly full-dose gem- citahine in patients with advanced pancreatic cancer[M]. J Clin Oncol, 2001,19:4202-4208.
  • 9Talamonti MS, Jr. WS, Mulcahy MF, et al. A multi-institu- tional phase Ⅱ trial of preoperative full-dose gemeitabine and concurrent radiation for patients with potentially reseetable pancreatic carcinoma[J]. Ann Surg Oncol, 2006, 13 : 150-158.
  • 10Small Jr. W, Berlin J, Freedman GM, et al. Full-dose gemcit abine with concurrent radiation therapy in patients with non- metastatic pancreatic cancer., a multicenter phase Ⅱ trial[J]. J Clin Oncol, 2008,26:942-947.

二级参考文献8

  • 1Jemal A, Siegel R, Ward E, et al. Cancer Statistics 2008. CA Cancer J Clin, 2008,58:71-96.
  • 2Lochan R, Daly AK, Reeves HL, et al, Genetic susceptibility in pancreatic ductal adenoearcinoma. Bri J Surg, 2008,95 : 22-32.
  • 3Hassan MM, Bondy ML, Wolff RA, et al. Risk Factors for Pancreatic Cancer: Case-Control Study. Am J Gastroenterol, 2007, 102: 2696-2707.
  • 4Katz MH, Hwang R, Fleming JB, et al. Tumor-node-metastasis staging of pancreatic adenocarcinoma. CA Cancer J Clin, 2008,58:111-125.
  • 5Raut CP, Tseng JF, Sun CC, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg, 2007,246 : 52- 60.
  • 6Westgaard A, Tafjord S, Farstad IN, et al, Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. BMC Cancer, 2008,14:5.
  • 7Samra JS, Gananadha S, Hugh TJ. Surgical management of carcinoma of the head of pancreas: extended iymphadenectomy of modified en bloc resection? ANZ J Surg, 2008, 78:228-236.
  • 8Farnell MB, Aranha GV, Nimura Y, et al. The role of extended lymphadenectomy for adenocareinoma of the head ofthe pancreas: strength of the evidence. J Gastrointest Surg, 2008, 12:651-656.

共引文献43

同被引文献53

  • 1孙丽萍,刘莉,陈东.胰腺癌放化疗的现状及研究进展[J].医学研究通讯,2005,34(5):59-60. 被引量:1
  • 2夏曙,于世英.抑制PI3K/Akt提高药物对HeLa细胞放射增敏作用的研究[J].中华放射肿瘤学杂志,2006,15(5):419-422. 被引量:9
  • 3Mei-lan HE,Ang LI,Chun-su XU,Shun-li WANG,Meng-jie ZHANG,Hua GU,Yao-qin YANG,Hui-hong TAO.Mechanisms of antiprostate cancer by gum mastic:NF-κB signal as target[J].Acta Pharmacologica Sinica,2007,28(3):446-452. 被引量:5
  • 4杨浩,梁喆,鞠躬,鲍璿.体外培养脊髓神经元过程中关于提高细胞产率以及活性的技术探讨[J].解剖学杂志,1997,20(3):239-242. 被引量:18
  • 5Xu D, Allsop SA, Witherspoon SM,et al. The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarci- noma ceils [ J ]. Carcinogenesis, 2011, 32 (4) :488-95.
  • 6Haqq J, Howells LM, Garcea G,et al. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies [ J ]. Eur J Cancer, 2014, 50 ( 15 ) :2570-82.
  • 7Passoni P, Reni M, Cattaneo GM, et al. Hypofractionated image- guided IMRT in advanced pancreatic cancer with simultaneous inte- grated boost to infiltrated vessels concomitant with capecitabine: a phase I study[J]. Int J Radiat Oncol Biol Phys, 2013, 87(5) : 1000-6.
  • 8Petit SF, Wu B, Kazhdan M, et al. Increased organ sparing using shape-based treatment plan optimization for intensity modulated ra- diation therapy of pancreatic adenocarcinoma [ J ]. Radiother Oncol, 2012, 102(1) :38-44.
  • 9Fujii T, Yamada S, Murotani K, et al. Nverse Probability of Treat- ment Weighting Analysis of Upfront Surgery Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Pancreatic Adenocar- cinoma with Arterial Abutment [ J ]. Medicine ( Baltimore ), 2015, 94(39) :e1647.
  • 10Combs SE, Habermehl D, Kessel KA,et al. Prognostic impact of CA 19-9 on outcome after neoadjuvant chemoradiation in patients with locally advanced pancreatic cancer [ J ]. Ann Surg Oncol, 2014, 21(8) :2801-7.

引证文献9

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部